Saizen (growth hormone disorders)

Merck offers wide range of pharmaceutical products and services which includes flow cytometry. It belongs to bioscience products category. Contact us for more information.

Merck offers wide range of pharmaceutical products and services which includes inhibitors and biochemicals. It belongs to bioscience products category. Contact us for more information.

Merck offers wide range of pharmaceutical products and services which includes iriodin.rtm. It belongs to high-tech chemicals liquid crystals products category. It is based on natural and synthetic mica and are provided with a thin metal oxide layer.

Merck offers wide range of pharmaceutical products and services which includes pharmaceutical & biopharmaceutical raw materials. It belongs to process solutions products category. Contact us for more information.

Merck offers wide range of pharmaceutical products and services which includes pyrisma®. It belongs to high-tech chemicals pig ments products category. It is based on natural mica. It is developed by the merck color space concept and cover the maximum color space.

Merck offers wide range of pharmaceutical products and services which includes multiplex instruments & kits. It belongs to bioscience products category. Contact us for more information.

Merck offers wide range of pharmaceutical products and services which includes organic & analytical chemicals. It belongs to lab solutions products category. Contact us for more information.

Merck offers wide range of pharmaceutical products and services which includes services to engineering & validation. It belongs to process solutions products category. Contact us for more information.

API Contract Manufacturing

Excipients / Formulation

Excipients / Formulation

Fine Chemicals and Intermediates

Merck will design the manufacturing process to help accelerate self-sufficient vaccine development and manufacturing in West Africa

The customization of single-use systems and cell culture media (CCM) presents significant opportunities for improving pharmaceutical manufacturing efficiencies, including reduced time, enhanced quality, and optimized resource utilization. However, the qualification of these custom products poses challenges, particularly regarding the systematic acquisition and evaluation of essential information.
This presentation will explore effective strategies for leveraging custom documentation to speed-up the qualification process of single-use assemblies and CCM. This includes: Key Criteria: Discussing the initial qualification criteria for selecting custom products Overcoming Obstacles: Evaluating common challenges and practical solutions in the qualification of custom single-use assemblies and CCM, Compliance Simplified: focus on quality and regulatory compliance documentation.

The new the 140,000-sq. ft facility will support commercialisation and industrialisation of viral vectors